Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Cardiogenic shock; Acute cardiac insufficiency; This is a spontaneous report from a non-contactable physician downloaded from the Agency Regulatory Authority-WEB (Regulatory Authority number DE-PEI-PEI2021002626). A 100 years old female received the first single dose of BNT162B2 (COMIRNATY) on 15Jan2021, for COVID-19 immunization. Medical history and concomitant medications were not reported. On 19Jan2021, four days after vaccination, the patient developed cardiogenic shock and acute cardiac insufficiency, lasting for 5 days. The patient died on an unspecified date in 2021. Cause of death was reported as acute cardiac insufficiency, however both cardiogenic shock and acute cardiac insufficiency were reported with a fatal outcome. Stop date of both events was reported as 23Jan2021 (death date was not clearly specified). It was unknown if an autopsy was done. Relatedness of drug to reaction(s)/event(s) assessed as D. Unclassifiable by Regulatory Authority. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Acute cardiac insufficiency; Cardiogenic shock
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166